Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe only legal route to Wegovy's 0.25mg starting dose in the UK is through a prescription, issued by a qualified prescriber after a clinical assessment of your health. Wegovy is a prescription-only medicine — no pharmacy, online or otherwise, can supply it without one. If you've been looking into this and feeling like the process is more complicated than it should be, that's a fair reaction: the landscape of online clinics varies enormously in quality and rigour. This page sets out exactly how a legitimate private prescription route works, what to look for in any provider you consider, and how nume's consultation process is structured — so you can make a straightforward, informed decision.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy is available on the NHS, but only through specialist weight management services and subject to criteria set by NICE's appraisal of semaglutide (TA875). In practice that means a referral, a multidisciplinary programme, and waiting lists that currently run to months or longer in most areas. Many people who qualify on paper cannot access treatment quickly through that route.
A private prescription sidesteps the wait entirely. The clinical bar does not disappear (a prescriber still assesses every application individually) but the timeline compresses from months to the same working day. If you're not sure whether your BMI and health history would meet the standard private eligibility criteria, the Wegovy overview page sets out the licensed thresholds in plain terms.
Worth being clear: choosing a private route does not mean a lower standard of care. It means a different funding model and a much shorter queue.
This is the decision that matters most for safety. The MHRA has issued repeated public warnings about fake weight-loss pens sold via social media and unverified websites, counterfeit pens have contained insulin and caused serious harm. In October 2025 the first illicit UK site manufacturing fake tirzepatide pens was raided; enforcement across 2025 resulted in roughly 20 million doses of illegally traded medicines (around £45m street value) being seized. The risk is real and ongoing.
Every legitimate UK online pharmacy must be registered with the General Pharmaceutical Council. You can check any pharmacy against the GPhC register directly, nume's registration number is 9012878. The check takes about thirty seconds and is the clearest signal you have that a supplier operates within the law. If a seller is offering Wegovy without a clinical assessment, at prices far below the market range, or via a social media DM, those are hard stops. Report suspect sellers at the MHRA's Yellow Card portal.
The full guide to buying Wegovy in the UK covers what else to look for when comparing providers.
Wegovy is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition, for example hypertension, high cholesterol, type 2 diabetes, prediabetes, or obstructive sleep apnoea. For some ethnic backgrounds, UK guidance applies a threshold that is 2.5 kg/m² lower. The NHS semaglutide page gives a reliable, plain-English account of how the medicine works and who it is used for.
BMI alone does not decide the outcome. A prescriber looks at your full picture: medical history, current medicines, any conditions that would make this treatment unsuitable. There are contraindications (pregnancy, breastfeeding, trying to conceive, certain thyroid conditions, a history of pancreatitis) and these are assessed at consultation, not assumed from a number. The nume FAQs page addresses the questions we hear most often from people at this stage.
One practical note: if you have existing private health insurance and wonder whether that changes anything, the guide to Wegovy and private health insurance is worth a read before you commit to any payment route.
The 0.25mg weekly dose is the first step of a titration schedule, not the dose at which most people see significant appetite changes. Its job is to let your system adjust to the medicine before the prescriber steps up the dose, reducing the likelihood of severe nausea or digestive discomfort in the early weeks. Treatment then climbs gradually through 0.5mg, 1mg, 1.7mg and eventually 2.4mg, with each step guided by how you're tolerating the current level. When the time comes to increase your injection, you can buy your Wegovy 0.5mg pen here once your prescriber confirms you're ready to move up, and later move on to the 1mg step-up dose once your prescriber is satisfied with your progress.
At nume, every repeat order is reviewed individually before dispatch. That means a named prescriber looks at your progress each time, not just at your first application. If you have questions between orders, aftercare is available seven days a week. You can also read more about 0.25mg stock availability if that is what prompted your search today.
The consultation is free, there is no subscription, and treatment pricing is shown clearly on the treatment page rather than buried in a checkout flow. Check your eligibility there when you're ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.